Early‐Onset Parkinsonism Is a Manifestation of the PPP2R5D p.E200K Mutation
- 22 August 2020
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 88 (5) , 1028-1033
Abstract
PPP2R5D‐related neurodevelopmental disorder is characterized by a range of neurodevelopmental and behavioral manifestations. We report the association of early‐onset parkinsonism with the PPP2R5D p.E200K mutation. Clinical characterization and exome sequencing were performed on three patients, with postmortem neuropathologic examination for one patient. All patients had mild developmental delay and developed levodopa‐responsive parkinsonism between the ages of 25 and 40 years. The PPP2R5D c.598G>A (p.E200K) mutation was identified in all patients. Neuropathologic examination demonstrated uneven, focally severe neuronal loss and gliosis in the substantia nigra pars compacta, without Lewy bodies. Our findings suggest the PPP2R5D p.E200K mutation to be a possible new cause of early‐onset parkinsonism. ANN NEUROL 2020;88:1028–1033Keywords
Funding Information
- Institute of Cancer Research
- Parkinson's Foundation
- JPB Foundation
- Association France Parkinson
- Simons Foundation
- National Institute on Aging
This publication has 19 references indexed in Scilit:
- B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disabilityJournal of Clinical Investigation, 2015
- Mutations in the PP2A regulatory subunit B family genesPPP2R5B,PPP2R5CandPPP2R5Dcause human overgrowthHuman Molecular Genetics, 2015
- Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein PhosphorylationThe Korean Journal of Physiology & Pharmacology, 2014
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancerCancer Letters, 2013
- De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthoodNature Genetics, 2013
- Mice lacking phosphatase PP2A subunit PR61/B’δ ( Ppp2r5d ) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3βProceedings of the National Academy of Sciences, 2011
- Twenty-first century brain banking. Processing brains for research: the Columbia University methodsActa Neuropathologica, 2007
- Crystal structure of a protein phosphatase 2A heterotrimeric holoenzymeNature, 2006
- Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient MiceJournal of Biological Chemistry, 2004
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983